FULGENT GENETICS, INC. Investment Income, Interest
FULGENT GENETICS, INC. (FLGT) reported Investment Income, Interest of $6.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-07-30
- FULGENT GENETICS, INC. investment income, interest for the quarter ending 2026-06-30 was $6.40M, a 20.85% decline year-over-year.
- FULGENT GENETICS, INC. investment income, interest for the quarter ending 2026-03-31 was $8.65M, a 7.89% increase year-over-year.
- FULGENT GENETICS, INC. investment income, interest for the quarter ending 2025-12-31 was $6.94M, a 14.61% decline year-over-year.
- FULGENT GENETICS, INC. investment income, interest for the quarter ending 2025-09-30 was $7.87M, a 2.67% decline year-over-year.
- FULGENT GENETICS, INC. investment income, interest for fiscal 2025 was $30.92M, a 1.23% decline from fiscal 2024.
- FULGENT GENETICS, INC. investment income, interest for fiscal 2024 was $31.30M, a 44.85% increase from fiscal 2023.
- FULGENT GENETICS, INC. investment income, interest for fiscal 2023 was $21.61M, a 284.28% increase from fiscal 2022.
- FULGENT GENETICS, INC. investment income, interest for fiscal 2022 was $5.62M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.40M 10-Q · filed 2026-07-30 | $15.05M 10-Q · filed 2026-07-30 | $21.99M derived: sum of 3 quarters · filed 2026-07-30 | $29.86M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $8.65M 10-Q · filed 2026-05-01 | $15.59M derived: sum of 2 quarters · filed 2026-05-01 | $23.46M derived: sum of 3 quarters · filed 2026-05-01 | $31.55M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $6.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $14.81M derived: sum of 2 quarters · filed 2026-02-27 | $22.90M derived: sum of 3 quarters · filed 2026-07-30 | $30.92M 10-K · filed 2026-02-27 |
| 2025-09-30 | $7.87M 10-Q · filed 2025-11-07 | $15.96M derived: sum of 2 quarters · filed 2026-07-30 | $23.98M 10-Q · filed 2025-11-07 | $32.11M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $8.09M 10-Q · filed 2026-07-30 | $16.11M 10-Q · filed 2026-07-30 | $24.23M derived: sum of 3 quarters · filed 2026-07-30 | $32.32M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $8.02M 10-Q · filed 2026-05-01 | $16.14M derived: sum of 2 quarters · filed 2026-05-01 | $24.23M derived: sum of 3 quarters · filed 2026-05-01 | $31.94M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $16.21M derived: sum of 2 quarters · filed 2026-02-27 | $23.92M derived: sum of 3 quarters · filed 2026-02-27 | $31.30M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.09M 10-Q · filed 2025-11-07 | $15.80M derived: sum of 2 quarters · filed 2025-11-07 | $23.18M 10-Q · filed 2025-11-07 | $28.99M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $7.71M 10-Q · filed 2025-08-01 | $15.09M 10-Q · filed 2025-08-01 | $20.90M derived: sum of 3 quarters · filed 2026-02-27 | $27.37M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $7.38M 10-Q · filed 2025-05-02 | $13.20M derived: sum of 2 quarters · filed 2026-02-27 | $19.67M derived: sum of 3 quarters · filed 2026-02-27 | |
| 2023-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.28M derived: sum of 2 quarters · filed 2026-02-27 | $21.61M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $6.47M 10-Q · filed 2024-11-08 | $15.80M 10-Q · filed 2024-11-08 | ||
| 2022-12-31 | $5.62M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |